Webb11 juni 2014 · Simulect Versus ATG in Sensitized Renal Transplant Patient (SATIR) October 24, 2024 updated by: University Hospital, Toulouse. Prospective, Multicenter, Randomized, Evaluating Two Induction Therapies With Simulect® Versus ATG® Fresenius Associated With Tacrolimus and Myfortic® in the Prevention of Treatment Failure, in Sensitized ... WebbSimulect® (basiliximab) for injection is a sterile, preservative-free lyophilisate, which is available in single-dose vials and is available in 10 mg and 20 mg strengths for …
Simulect® (Basiliximab) – Individual Exchange Medical Benefit Drug Policy
Webb10 maj 2012 · It will be conducted in low risk de novo adult renal transplant recipients until 12 weeks post-transplant, receiving either a cumulative dose of 40 or 80 mg of Simulect® in combination with Neoral®, or a cumulative dose of 80 mg of Simulect® in a calcineurin inhibitor free immunosuppressant therapy. Study Design Go to Webb3 apr. 2024 · Simulect ® (basiliximab) is a chimeric (murine/human) monoclonal antibody (IgG 1к ), produced by recombinant DNA technology, that functions as an immunosuppressive agent, specifically binding to and blocking the interleukin-2 receptor α-chain (IL-2Rα, also known as CD25 antigen) on the surface of activated T-lymphocytes. chroniker meaning
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS - European …
Webb15 okt. 2024 · At transplantation time all patients received induction therapy, consisted of either basiliximab (Simulect; Novartis Pharmaceuticals Corp., East Hanover, NJ) or rabbit anti-thymocyte globulin (rATG; Thymoglobulin; Genzyme, Cambridge, MA) in association with steroids, according to donor (standard or ECD) and recipient characteristics (i.e. … WebbSimulect fungerar genom att stoppa immuncellerna som angriper transplanterade organ. Du får bara två doser Simulect. Dessa ges på sjukhus, i samband med transplantationen. … WebbSimulect kan ges till äldre patienter, men tillgänglig information är begränsad. Din läkare kan komma att diskutera detta med dig innan du får Simulect. Barn och ungdomar (1–17 år) Simulect kan ges till barn och ungdomar. Dosen till barn som väger under 35 kg är lägre än den som vanligen ges till vuxna. chronik firefox